Malaysia at a glance
- Population
- 36.0 million 2025
- Life expectancy at birth
- 76.8 years, 2024
- People aged 65 and over
- 8.0 % of people, 2025
- Health spending per person
- 450 US$ per person, 2023
- Doctors
- 2.34 per 1,000 people, 2023
Updated
Reviewed by Chandani Patel
Malaysia Cardiac Biomarker Testing Market Industry Trends and Forecast to 2034: Segmented by (Biomarker, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$12.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $12.8 Mn | — | — |
| 2025 (base) | $13.8 Mn | +$1.0 Mn | — |
| 2026 (forecast) | $14.8 Mn | +$1.0 Mn | +7.6% |
| 2027 (forecast) | $16.0 Mn | +$1.1 Mn | +15.8% |
| 2028 (forecast) | $17.2 Mn | +$1.2 Mn | +24.6% |
| 2029 (forecast) | $18.5 Mn | +$1.3 Mn | +34% |
| 2030 (forecast) | $19.9 Mn | +$1.4 Mn | +44.2% |
| 2031 (forecast) | $21.4 Mn | +$1.5 Mn | +55.2% |
| 2032 (forecast) | $23.0 Mn | +$1.6 Mn | +67% |
| 2033 (forecast) | $24.8 Mn | +$1.7 Mn | +79.7% |
| 2034 (forecast) | $26.6 Mn | +$1.9 Mn | +93.3% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $13.8 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $26.6 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Also called | Cardiac Marker Testing |
| Segments | Biomarker, setting and end user (see all) |
| Key players | Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Beckman Coulter (Danaher), Quidel Corporation (see all) |
| Regulator in Malaysia | MDASource: Medical Device Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Cardiac biomarker tests measure proteins such as troponin and BNP in blood to diagnose heart attacks and heart failure.
Key segments of the cardiac Biomarker Testing market include biomarker (Troponin, BNP and NT-proBNP and CK-MB) and setting (Central Labs and Point of Care).
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the cardiac Biomarker Testing market.
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the cardiac Biomarker Testing market room to grow, especially in emerging markets.
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the cardiac Biomarker Testing market.
The cardiac Biomarker Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices must be registered with the Medical Device Authority (MDA) under the Medical Device Act 2012.[1] Public clinics and hospitals run by the Ministry of Health give heavily subsidised care.[2]
[1] Medical Device Authority. Checked 14 Nov 2026.
[2] Ministry of Health Malaysia. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how cardiac Biomarker Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Malaysia.
What doctors and scientists are doing in Cardiac Biomarker Testing right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
From our blog
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia
Malaysia
Digital Health · Malaysia
Digital Health · Malaysia
Healthcare Services · Malaysia
Pharmaceuticals · Malaysia
Pharmaceuticals · Malaysia
Healthcare Services · Malaysia